EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Former long‐term use of combined hormonal contraception and glucose metabolism disorders in perimenopausal women: A prospective, population‐based cohort study

Maria-Elina Mosorin iD, Meri-Maija Ollila iD, Tanja Nordström, Jari Jokelainen, Terhi Piltonen, Juha Auvinen, Laure Morin-Papunen, Juha Tapanainen iD

Acta Obstetricia et Gynecologica Scandinavica · 2023

DOI: 10.1111/aogs.14636 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, 2023. Verfasst von Maria-Elina Mosorin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Oulu University Hospital, Wellbeing Services County of North Ostrobothnia, University of Oulu, Oulu, Finland. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glucose Metabolism Disorders, Hormonal Contraception, Prediabetic State. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Academy of Finland, ERDF European Regional Development Fund Grant, Helsinki University Hospital Research Funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Current use of combined hormonal contraceptives worsens glucose tolerance and increases the risk of type 2 diabetes mellitus at late fertile age, but the impact of their former use on the risk of glucose metabolism disorders is still controversial. Material and methods This was a prospective, longitudinal birth cohort study with long‐term follow‐up consisting of 5889 women. The cohort population has been followed at birth, and at ages of 1, 14, 31 and 46. In total, 3280 (55.7%) women were clinically examined and 2780 also underwent a 2‐h oral glucose tolerance test at age 46. Glucose metabolism indices were analyzed in former combined hormonal contraceptive users ( n = 1371) and former progestin‐only contraceptive users ( n = 52) and in women with no history of hormonal contraceptive use ( n = 253).

Results

Compared with women with no history of hormonal contraceptive use, those who formerly used combined hormonal contraceptives for over 10 years had an increased risk of prediabetes (odds ratio [OR] 3.9, 95% confidence interval [CI]: 1.6–9.2) but not of type 2 diabetes mellitus. Former progestin‐only contraceptive use was not associated with any glucose metabolism disorders. The results persisted after adjusting for socioeconomic status, smoking, alcohol consumption, parity, body mass index and use of cholesterol‐lowering medication.

Conclusions

Former long‐term use of combined hormonal contraceptives was associated with a significantly increased risk of prediabetes in perimenopausal women, which potentially indicates a need of screening for glucose metabolism disorders in these women.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Glucose Metabolism DisordersHormonal ContraceptionPrediabetic StateFemaleHumansInfant, NewbornMiddle AgedCohort StudiesContraceptionContraceptives, Oral, CombinedContraceptives, Oral, HormonalPerimenopauseProgestinsProspective Studies

Stichwörter der Autor:innen

OGTTcombined hormonal contraceptionglucose metabolism disordersprediabetesprogestin-only contraceptiontype 2 diabetes mellitus

Substanzen

Contraceptives, Oral, CombinedContraceptives, Oral, HormonalProgestins

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Oulu University Hospital, Wellbeing Services County of North Ostrobothnia, University of Oulu, Oulu, Finland.
  • Medical Research Center, Oulu University Hospital, University of Oulu, Wellbeing Services County of North Ostrobothnia, Oulu, Finland.
  • Research Unit of Clinical Medicine Oulu University Hospital, University of Oulu, Wellbeing Services County of North Ostrobothnia, Oulu, Finland.
  • Center for Life Course Health Research, University of Oulu, Wellbeing Services County of North Ostrobothnia, Oulu, Finland.
  • Unit of General Practice, Oulu University Hospital, Wellbeing Services County of North Ostrobothnia, Oulu, Finland.
  • Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

ORCID-Profile: Maria-Elina Mosorin, Meri-Maija Ollila, Juha Tapanainen

Förderung

  • Academy of Finland
  • ERDF European Regional Development Fund Grant
  • Helsinki University Hospital Research Funds
  • Oulu University Hospital Grant
  • Oulu University Hospital Research Funds
  • Oulu University Medical Research Center
  • Sigrid Juselius foundation
  • University of Oulu Grant

Zitieren

APA

Mosorin, M. E., Ollila, M. M., Nordström, T., Jokelainen, J., Piltonen, T., Auvinen, J., Morin-Papunen, L., & Tapanainen, J. (2023). Former long‐term use of combined hormonal contraception and glucose metabolism disorders in perimenopausal women: A prospective, population‐based cohort study. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.14636

Vancouver

Mosorin ME, Ollila MM, Nordström T, Jokelainen J, Piltonen T, Auvinen J, et al. Former long‐term use of combined hormonal contraception and glucose metabolism disorders in perimenopausal women: A prospective, population‐based cohort study. Acta Obstetricia et Gynecologica Scandinavica. 2023. doi:10.1111/aogs.14636

BibTeX
@article{Mosorin2023,
  author = {Mosorin, Maria-Elina and Ollila, Meri-Maija and Nordström, Tanja and Jokelainen, Jari and Piltonen, Terhi and Auvinen, Juha and Morin-Papunen, Laure and Tapanainen, Juha},
  title = {Former long‐term use of combined hormonal contraception and glucose metabolism disorders in perimenopausal women: A prospective, population‐based cohort study},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2023},
  doi = {10.1111/aogs.14636}
}
Kostenlos starten →